Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms
Hyelnaya Cletus Sharndama, Ifeanyi Elibe
Brazilian Journal of Microbiology (2022) Vol. 53, Iss. 1, pp. 33-50
Open Access | Times Cited: 147

Showing 1-25 of 147 citing articles:

Helicobacter pylori Infection: Current Status and Future Prospects on Diagnostic, Therapeutic and Control Challenges
Ayman Elbehiry, Eman Marzouk, Musaad Aldubaib, et al.
Antibiotics (2023) Vol. 12, Iss. 2, pp. 191-191
Open Access | Times Cited: 96
Helicobacter Pylori and Autoimmune Diseases: Involving Multiple Systems
Li Wang, Zheng-Min Cao, Lili Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 79
Helicobacter pylori infection in humans and phytotherapy, probiotics, and emerging therapeutic interventions: a review
Mengkai Liu, Hui Gao, Jinlai Miao, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 18
Helicobacter pylori in the post-antibiotics era: from virulence factors to new drug targets and therapeutic agents
Omnia Momtaz Al-Fakhrany, Engy Elekhnawy
Archives of Microbiology (2023) Vol. 205, Iss. 9
Open Access | Times Cited: 23
Research progress on Helicobacter pylori infection related neurological diseases
Fan Wang, Zhendong Yao, Tao Jin, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102399-102399
Closed Access | Times Cited: 9
Indole-3-Lactic Acid Derived from Lacticaseibacillus paracasei Inhibits Helicobacter pylori Infection via Destruction of Bacteria Cells, Protection of Gastric Mucosa Epithelial Cells, and Alleviation of Inflammation
Mengke Yao, Junhan Cao, Ping Zhang, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 28, pp. 15725-15739
Closed Access | Times Cited: 8
Effect of Helicobacter pylori–induced gastric cancer on gastrointestinal microbiota: a narrative review
Mohsen Heidary, Sousan Akrami, Tohid Madanipour, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access | Times Cited: 1
Chitosan Nanoparticles for Enhanced Immune Response and Delivery of Multi-Epitope Helicobacter pylori Vaccines in a BALB/c Mouse Model
Rita Amaral, Tomás Concha, Jorge M. B. Vítor, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 132-132
Open Access | Times Cited: 1
Flagella at the Host-Microbe Interface: Key Functions Intersect With Redundant Responses
Douglas T. Akahoshi, Charles Bevins
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
Biomaterials for Helicobacter pylori therapy: therapeutic potential and future perspectives
Yongkang Lai, Wei Wei, Yiqi Du, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 33
Helicobacter pylori and the Role of Lipopolysaccharide Variation in Innate Immune Evasion
Daniel Sijmons, Andrew J. Guy, Anna K. Walduck, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Current and Future Perspectives in the Diagnosis and Management of Helicobacter pylori Infection
Malek Shatila, Anusha Shirwaikar Thomas
Journal of Clinical Medicine (2022) Vol. 11, Iss. 17, pp. 5086-5086
Open Access | Times Cited: 29
The Influence of Helicobacter pylori on Human Gastric and Gut Microbiota
Marcello Fiorani, Ege Tohumcu, Livio Enrico Del Vecchio, et al.
Antibiotics (2023) Vol. 12, Iss. 4, pp. 765-765
Open Access | Times Cited: 20
Reactive Oxygen Species and H. pylori Infection: A Comprehensive Review of Their Roles in Gastric Cancer Development
Dhiraj Kumar Sah, Archana Arjunan, Bora Lee, et al.
Antioxidants (2023) Vol. 12, Iss. 9, pp. 1712-1712
Open Access | Times Cited: 17
A review on the research progress on non-pharmacological therapy of Helicobacter pylori
Qian Luo, Na Liu, Sugui Pu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 13
Helicobacter pylori infection altered gastric microbiota in patients with chronic gastritis
Zhaolai Hua, Le Xu, Jiahui Zhu, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 13
<i>Helicobacter pylori</i> Diagnosis and Treatment in Africa: The First Lagos Consensus Statement of the African Helicobacter and Microbiota Study Group
Stella Ifeanyi Smith, Christian Schulz, Rose Ugiagbe, et al.
Digestive Diseases (2024) Vol. 42, Iss. 3, pp. 240-256
Closed Access | Times Cited: 5
Antitumor Effects of Resveratrol Opposing Mechanisms of Helicobacter pylori in Gastric Cancer
D. Trautmann, Francesca Suazo, Keila Torres, et al.
Nutrients (2024) Vol. 16, Iss. 13, pp. 2141-2141
Open Access | Times Cited: 5
Clinical Factors Implicated in Antibiotic Resistance in Helicobacter pylori Patients
Brian White, Maria Winte, Joshua DeSipio, et al.
Microorganisms (2022) Vol. 10, Iss. 2, pp. 322-322
Open Access | Times Cited: 22
Efficacy and Tolerability of 14-Day Tegoprazan- versus Rabeprazole-Based Triple Therapy for Eradication of Helicobacter pylori: A Real-World Evidence Study
Yoon Suk Jung, S. Kim, Hyun-Young Kim, et al.
Gut and Liver (2022) Vol. 17, Iss. 5, pp. 711-721
Open Access | Times Cited: 20
Correlation between Chemical Profile of Georgian Propolis Extracts and Their Activity against Helicobacter pylori
Jarosław Widelski, Piotr Okińczyc, Katarzyna Suśniak, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1374-1374
Open Access | Times Cited: 12
How Long Will It Take to Launch an Effective Helicobacter pylori Vaccine for Humans?
Songhui Li, Wenfeng Zhao, Lei Xia, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 3787-3805
Open Access | Times Cited: 12
Prevalence of Helicobacter pylori genotypes: cagA, vacA (m1), vacA (s1), babA2, dupA, iceA1, oipA and their association with gastrointestinal diseases. A cross-sectional study in Quito-Ecuador
Santiago Bustos-Fraga, Marco Salinas, Yosselin Vicuña-Almeida, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Targeted nanotherapeutics for the treatment of Helicobacter pylori infection
Rute Chitas, Diana R. Fonseca, Paula Parreira, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 4
Prevalence and risk factors associated with metabolic dysfunction-associated steatohepatitis in patients with Helicobacter pylori infection: A population-based study
Rashid Abdel-Razeq, Lynn Bitar, E Bitar, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 10, pp. 1169-1176
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top